Cynata Therapeutics Limited has released a press release.
Reinstatement to Official Quotation
Earlier from Cynata Therapeutics
- CYP-001 GvHD Trial Primary Evaluation Results
- Suspension from Quotation
- EU Positive Opinion on CYP-001 Paediatric Investigation Plan
- Cynata Secures Commitments for $1.5m Placement